What Novartis România does

Novartis România is the Romanian operating subsidiary of Novartis AG, a Swiss global pharmaceutical company publicly traded on the NYSE (NVS). Established in 1996 and headquartered in Sector 2, Bucharest, the company employs approximately 109 people and operates across three divisions: Novartis Pharma, Novartis Oncology, and Sandoz. Its portfolio covers five therapeutic areas — cardiovascular, renal and metabolic; immunology; neuroscience; and oncology — through prescription medicines distributed via licensed pharmacies and healthcare facilities across Romania.

The company engages healthcare professionals and institutions through an enterprise field sales model staffed by medical representatives, supported by a set of branded digital platforms: iNOVmed (medical resources for HCPs), Eu vreau să știu (patient information), and Dincolo de Piele (psoriasis patient support). These channels are supplemented by participation in medical congresses and LinkedIn presence. The company does not publicly disclose product pricing; revenue is generated through standard prescription-pharmaceutical sales, with pricing determined through healthcare system reimbursement and insurance mechanisms.

The business is conducted under a strategic-operating parent-subsidiary structure, with the Romanian entity receiving Top Employer certification in 2024, 2025, and 2026. Beyond the core prescription business, Novartis România has launched access initiatives such as Tratamentul la îndemână (Treatment within Reach) and digital-innovation programs including ChallengeIT and a Digital Health Pre-Accelerator in AI & Robotics, alongside partnerships with the Romanian healthcare system, the Bill & Melinda Gates Foundation, and local environmental organizations. Revenue figures for the Romanian subsidiary are not publicly disclosed.

Name

Novartis România

Legal name

Novartis AG

Website

https://novartis.com.ro

Company type

Public

Operating status

Operating

Headcount range

101–250 employees

Short description

Novartis România is the Romanian subsidiary of Novartis AG, distributing prescription pharmaceutical products across cardiovascular, immunology, neuroscience, and oncology therapeutic areas, alongside generics via Sandoz, to patients, healthcare professionals, and institutions in Romania.

Ownership category

akta.pro rank

Product category

Prescription Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Neurology & Psychiatry (CNS) Pharmaceuticals (HLAIAAAF)

akta.pro secondary industries

Cardiology & Vascular Specialty Pharmaceuticals (HLAIACAG), Medical Oncology (HLAKAFAB)

Keywords

• Prescription pharmaceuticals
• Innovative medicines
• Oncology treatments
• Therapeutic areas
• Generic pharmaceuticals

Headquarters

HQ city

Bucharest

HQ country

Romania

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Prescription Pharmaceuticals: Novartis Romania generates revenue through the sale of prescription pharmaceutical products including innovative medicines across therapeutic areas such as cardiovascular, immunology, neuroscience, and oncology. The company operates through divisions including Novartis Pharma, Novartis Oncology, and Sandoz.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Novartis România develops, markets, and distributes innovative prescription pharmaceutical products across five therapeutic areas: Cardiovascular, Renal and Metabolic; Immunology; Neuroscience; and Oncology, through its Novartis Pharma, Novartis Oncology, and Sandoz divisions. The company supplements its medicines portfolio with digital support platforms — iNOVmed for healthcare professionals, Eu Vreau să Știu for patient education, and Dincolo de Piele for psoriasis patients — to improve treatment access and outcomes for Romanian patients.

Product overview

Novartis România operates as the Romanian subsidiary of Novartis AG, an innovative medicines company. The company offers a unified product portfolio spanning five therapeutic areas: Cardiovascular, Renal and Metabolic; Immunology; Neuroscience; and Oncology. The portfolio includes both pharmaceutical products and digital platforms such as the iNOVmed platform for healthcare professionals, the Dincolo de Piele psoriasis patient support platform, and the Eu Vreau să Ştiu patient information resource. The company focuses on developing innovative therapies and making them accessible to Romanian patients.

Differentiator

Problem solved

Functional benefit

Products and services

• Novartis România Pharmaceutical Product Portfolio Innovative prescription medicines spanning five therapeutic areas (Cardiovascular/Renal/Metabolic, Immunology, Neuroscience, Oncology) marketed and distributed in Romania through the Novartis Pharma and Novartis Oncology divisions for patients with serious diseases.
• Dincolo de Piele Digital patient support platform for psoriasis patients in Romania, providing disease information, treatment resources, and support tools for those living with the condition.
• iNOVmed Digital platform providing medical information, clinical resources, and scientific content for doctors, physicians, and healthcare professionals in Romania.
• Eu Vreau să Știu Digital patient information and awareness platform providing educational resources about various health conditions for Romanian patients and their families.
• Sandoz Generic Pharmaceuticals Division Generic pharmaceutical product line offered in Romania through the Sandoz division of Novartis Group, providing a comprehensive portfolio of cost-effective medications alongside innovative medicines.

Quantifiable outcome

• 296 million people reached with Novartis medicines worldwide
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Ten partnerships are on record, tiered supporting and core.

• ChallengeITsupportingStrategic or Co-development Partner · 31 October 2022Digital solutions initiative for better medical services. Novartis Romania launched ChallengeIT to promote digital innovations for healthcare improvement.
• Romanian Healthcare SystemcoreOthers · 31 October 2022Novartis Romania divisions (Novartis Pharma, Novartis Oncology, Sandoz) support the Romanian healthcare system with approximately USD 480,000 for COVID-19 relief, demonstrating partnership with the national healthcare infrastructure.
• Digital Health Pre-Accelerator AI & RoboticssupportingStrategic or Co-development Partner · 31 October 2022Initiative promoting research and entrepreneurship in university environments. Novartis Romania supports digital health innovation through university partnerships.
• Bill & Melinda Gates FoundationsupportingStrategic or Co-development Partner · 31 October 2022Global partnership to combat the COVID-19 pandemic. Novartis joined with the Gates Foundation and other science companies to provide expertise and resources against COVID-19.
• Dincolo de PielesupportingGTM or Marketing PartnerPatient support platform for psoriasis patients, providing information and support resources for patients with skin conditions in Romania. Novartis partners with this platform to extend patient reach and support.
• iNOVmedcoreGTM or Marketing PartnerComprehensive resource platform for healthcare professionals in Romania providing medical information, clinical resources, and scientific content. Primary channel for healthcare professional engagement in Romania.
• Eu vreau să știusupportingGTM or Marketing PartnerPatient information platform providing disease awareness and treatment information for Romanian patients. Extends Novartis patient education and engagement capabilities.
• SandozcoreOthersSandoz is a division of Novartis Group Romania, focusing on generic pharmaceuticals. The division operates within the Novartis structure alongside Novartis Pharma and Novartis Oncology to provide a comprehensive portfolio of medications.
• Asociația Mai Mult VerdesupportingStrategic or Co-development PartnerRomanian environmental organization. Novartis Romania volunteers collaborated with the association for Danube cleanup activities.
• Asociația Pădurea CopiilorsupportingStrategic or Co-development PartnerRomanian reforestation organization. Novartis Romania supports reforestation and local community development through this partnership.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Sanofi România: Sanofi România is a direct competitor selling innovative and specialty medicines across cardiovascular, immunology, and rare diseases in Romania through a similar enterprise field sales model. Comparable in scale, market presence, and therapeutic area breadth to Novartis România.
• Pfizer România: Pfizer România is the local subsidiary of Pfizer, one of the largest global pharma companies, selling innovative medicines across similar therapeutic areas (oncology, cardiovascular, immunology) through field sales to HCPs in Romania. It is the closest direct competitor to Novartis România in terms of multinational pharma presence and therapeutic portfolio overlap in the Romanian market.
• AstraZeneca România: AstraZeneca România is a direct competitor with a portfolio strongly overlapping in cardiovascular/renal/metabolic and oncology therapeutic areas. Both companies compete for HCP share in cardiology and oncology institutions across Romania.
• Roche România: Roche România is the local affiliate of Roche, a major competitor in oncology and specialty pharmaceuticals in Romania. Both Novartis and Roche operate parallel oncology divisions in the country and compete for HCP share in the same teaching hospitals and academic centers.
• Johnson & Johnson România: Johnson & Johnson România operates Janssen pharmaceutical sales in Romania with a strong oncology and immunology portfolio. Directly competes with Novartis România for prescriber share in immunology and oncology.
• Bayer România: Bayer România is the local subsidiary of Bayer, competing with Novartis in cardiovascular care and specialty pharma. Both companies use field sales, HCP engagement, and patient access programs in Romania.
• GlaxoSmithKline România: GSK România is a multinational pharma subsidiary selling innovative medicines and vaccines in Romania, with portfolio overlap in immunology and specialty therapeutics and a similar commercial approach.
• AbbVie România: AbbVie România is a direct competitor in immunology and specialty pharmaceuticals, particularly in psoriasis (overlapping with Novartis's Dincolo de Piele platform) and other immunology indications where both companies market biologics.
• MSD România: MSD (Merck) România is a direct competitor in oncology and innovative pharmaceuticals in Romania, with comparable portfolio breadth across multiple therapeutic areas and similar commercial model targeting HCPs and institutions.
• Eli Lilly România: Eli Lilly România is a direct competitor in innovative medicines across oncology, immunology, and cardiovascular metabolic conditions, with a comparable commercial model targeting Romanian HCPs and healthcare institutions.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks3 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/novartis-romania

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novartis România